Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
12/2005
12/28/2005EP1299352B1 Compounds to treat alzheimer's disease
12/28/2005EP1000932B9 Aromatic ring derivatives
12/28/2005CN1714070A Vitamin d receptor modulators
12/27/2005CA2305463C Aminobutanoic acid derivatives
12/27/2005CA2256332C Substituted sulphonyl amino(thio)carbonyl compounds and their use as herbicides
12/22/2005WO2005121078A2 Substituted cyclopentene compounds
12/22/2005WO2005061443A3 Benzoyl-substituted phenylalanine amides
12/22/2005US20050282899 Resorcinol derivatives
12/22/2005US20050282872 Novel thyroid receptor ligands and method II
12/21/2005EP1606248A2 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
12/21/2005EP1363878A4 Process for preparing sulfamoyl-substituted phenethylamine derivatives
12/21/2005CN1711236A Nitroaniline-based alkylating agents and their use as prodrugs
12/20/2005CA2174127C Phenylsulfonyl ureas, processes for their preparation, and their use as herbicides and plant growth regulators
12/15/2005WO2005119315A2 Non-linear optically active molecules, their synthesis, and use
12/15/2005WO2005118529A2 Process for making n-sulfonated-amino acid derivatives
12/15/2005WO2005118528A2 Aryl alkyl sulfonamides as therapeutic agents for the treatment of bone conditions
12/15/2005WO2005118527A2 Fluorous capping reagents, and methods for peptide purification
12/15/2005US20050276750 2-Amino-4-{(2-{(3-amino-3-carboxy-propyl)-[2-(4-methoxy-benzylsulfanyl)-ethyl]-amino}-ethyl)-[2-(4-methoxy-benzylsulfanyl)-ethyl]-amin o}-butyric acid; detection of cells undergoing apoptosis, blood clot, activated inflammatory cells, cell death within tumor, metastases, cell having perturbed membrane
12/15/2005CA2566191A1 Process for making n-sulfonated-amino acid derivatives
12/15/2005CA2565705A1 Non-linear optically active molecules, their synthesis, and use
12/14/2005EP1604976A1 Nimesulide derivative method for its preparation and a pharmaceutical composition containing the same
12/14/2005EP1604212A2 Modulators of the g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
12/14/2005EP1603891A1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid
12/14/2005EP1603866A1 A process for the preparation of enantiomerically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide
12/14/2005EP1603864A2 Diphenylethylene compounds and uses thereof
12/14/2005EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds
12/14/2005EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES
12/14/2005CN1231465C Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament
12/14/2005CN1231439C Novel hydronaphtalene compounds prepared by phodium catalyzed ring opening reaction in presence of phosphine ligand
12/13/2005US6974876 Method for preparing intermediates useful in synthesis of retroviral protease inhibitors
12/08/2005US20050272955 Substituted cyclopentene compounds
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272815 Compounds and compositions for delivering active agents
12/08/2005US20050272774 Substituted cyclohexane derivatives
12/08/2005US20050272036 Ketones
12/08/2005DE102004023508A1 Säurederivate substituierter Cyclohexyl-1,4-diamine Acid derivatives substituted cyclohexyl-1,4-diamine
12/07/2005EP1602368A2 Cdc25 phosphatase inhibitors
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005CN1705642A Novel N-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972300 Compounds and compositions for delivering active agents
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/06/2005CA2206787C 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same
12/06/2005CA2096528C Retroviral protease inhibitors
12/01/2005WO2005113513A2 Aryl sulfonamides
12/01/2005WO2005113490A1 Sulfone-containing prodrugs
12/01/2005WO2005113489A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
12/01/2005WO2005080313A3 Sulfonamide derivatives for the treatment of diseases
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005060456A3 Method for treating adamts-5-associate disease
12/01/2005US20050267315 Method for friedel-crafts acylation of anilides
12/01/2005US20050267215 Abca-1 elevating compounds
12/01/2005US20050267206 Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
12/01/2005US20050267199 2-Amino- and 2-thio- substituted 1,3-diaminopropanes
12/01/2005US20050267183 Selective estrogen receptor modulators
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267149 Benzoic acid derivatives as modulators of ppar alpha and gamma
12/01/2005US20050267032 Sulfone-containing prodrugs
12/01/2005US20050266289 dialysis system or a two-phase reactor or a fuel cell containing a membrane comprised of a crosslinked copolymer; Exhibit extensive delocalization of negative charge; allow the preparation of macromolecules possessing dissociated and stable ionic functional groups
12/01/2005CA2566387A1 Aryl sulfonamides as chemokine receptor ccr9 antagonists
12/01/2005CA2566090A1 Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies
11/2005
11/30/2005EP1599490A1 Process for the preparation of anticonvulsant derivatives of topiramate
11/30/2005EP1294683B1 A process for preparing biphenyl compounds
11/30/2005EP1259485B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa
11/30/2005EP1185518B1 Alpha-phenyl-beta-ketosulfone
11/30/2005EP1159278B1 Inhibitors of aspartyl protease
11/30/2005EP1144372B1 Sulphohydroxamic acids and sulphohydroxamates and their use as mek inhibitors
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1702064A Sulfonyl urea compounds and herbicidal activity thereof
11/30/2005CN1229355C Substituted fluoroalcoxyphenylsulfonylurea
11/30/2005CN1229340C 3-oxa perfluoro-nonyl fluorocarbon surfactant, its synthesizing method and usages
11/29/2005US6969703 Inhibitors of the ICE/ced-3 family of cysteine proteases
11/24/2005WO2005110973A1 Acid derivatives of substituted cyclohexyl-1,4-diamines
11/24/2005WO2005090296A3 N-substituted benzene sulfonamides
11/24/2005WO2005077884A3 Hydroaminomethylation of olefins
11/24/2005US20050261346 N-(5-bromo-2-pyridinyl)-(2-4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenylcarboxamide;modified amidine elements of high potency in vitro, excellent pharmacological and pharmaceutical properties in vivo
11/24/2005US20050261332 Sulfonamides and uses thereof
11/24/2005US20050261286 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261264 Rare-earth ternary complex
11/24/2005US20050258553 Method for the organometallic production of organic intermediate products comprising carbon-heteroatom bonds achieved by the deprotonation of heteroatoms
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1701059A Chemotherapeutic agents
11/22/2005US6967196 Sulfonamide compounds and uses thereof
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005US20050256201 Phenethanolamine derivatives
11/17/2005US20050256191 Nitroaniline-based alkylating agents and their use as prodrugs
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/16/2005EP1594845A2 Benzene acetamide compounds useful as serine protease inhibitors
11/16/2005EP1594505A2 Phenylglycine derivatives useful as serine protease inhibitors
11/16/2005CN1697828A New compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
11/16/2005CN1227222C Ternary sulfonimine transition metal salt and synthesis method thereof
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 177